Celsion Breast Cancer Device Trials In Progress: Preliminary Data Favorable
This article was originally published in The Gray Sheet
Executive Summary
Celsion plans to submit a PMA application for the Microfocus APA1000 (adaptive phased array) early-stage primary breast cancer treatment by the second half of 2004